First Time Us Pharmaceuticals (India) Private Limited

First Time Us Pharmaceuticals (India) Private Limited - healthcare in Navi Mumbai, Maharashtra, India. FY 2026 financials & compliance.
CIN U74999MH2013FTC244256 Incorporated 10 June 2013 ROC Mumbai HQ Navi Mumbai, Maharashtra, India
Active Foreign Private Limited Company healthcare
Data last updated
Revenue · FY 2025
₹10.72 Cr
▲ 7% YoY
Net loss · FY 2025
₹1.31 Cr
Net margin -12.2%
EBITDA · FY 2025
-₹1.01 Cr
EBITDA margin -9.4%
Authorised capital
₹6 Cr
Registered with MCA
Paid-up capital
₹4.37 Cr
Issued & subscribed
Company age
13 yrs
Est. 2013
Employees · EPFO
48
Provident fund records
Directors on board
3
As per MCA filings

About First Time Us Pharmaceuticals (India) Private Limited

Data last updated:

First Time Us Pharmaceuticals (India) Private Limited is a foreign private limited company based in Navi Mumbai, Maharashtra, India, a subsidiary of First Time Us Generics Llc. It operates in the medical equipment retail and distribution segment of the healthcare sector. It was incorporated on 10 June 2013 and has been in existence for over 13 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2013FTC244256. Its GSTIN is 27AACCF2726R1Z7 (Maharashtra).

The company has an authorised share capital of ₹6 Cr and a paid-up capital of ₹4.37 Cr. It is led by directors including Vibhor Shirish Misar and Manesh Ashok Dixit.

Its last annual general meeting (AGM) was held on 30 October 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C – 112 Pawane T.T.C Industrial Area M.I.D.C., Navi Mumbai, Maharashtra, India – 400705.

As per the financials filed for FY 2025, the company reported a revenue of ₹10.72 Cr, a growth of 7% compared to the previous year. For the same year it recorded a net loss of ₹1.31 Cr (net margin -12.2%) and EBITDA of -₹1.01 Cr (EBITDA margin -9.4%). Revenue has grown at a compounded annual rate (CAGR) of 12% over three years and 11% over five years.

The company has about 48 employees on its provident fund (EPFO) records.

Court records list 1 case involving the company, including 1 filed by the company. The company has 4 deals on record (4 rights issues); the latest was in January 2019.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website firsttimeusgenerics.com.

Company details

CIN U74999MH2013FTC244256
Registration Number 244256
Incorporation Date 10 June 2013
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 October 2025
Date of Balance Sheet 31 March 2025
Parent Company First Time Us Generics Llc
Compliance Status Active Compliant

Contact details

First Time Us Pharmaceuticals (India) Private Limited's registered office is in Navi Mumbai, Maharashtra. Its website is firsttimeusgenerics.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    C – 112 Pawane T.T.C Industrial Area M.I.D.C., Navi Mumbai, Maharashtra, India – 400705
  • Industry
    Healthcare, Medical Equipment Retail & Distribution

To see the full contact details of First Time Us Pharmaceuticals (India) Private Limited, buy the company report.

Comprehensive company report
First Time Us Pharmaceuticals (India) Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of First Time Us Pharmaceuticals (India) is professional, scientific and technical. In detail, this covers other professional, scientific and technical activities.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
MProfessional, Scientific and TechnicalM9Other professional, scientific and technical activities

To see the full business activity and turnover split of First Time Us Pharmaceuticals (India) Private Limited, buy the company report.

Financials of First Time Us Pharmaceuticals (India) Private Limited

FY 2025 filings available

First Time Us Pharmaceuticals (India) Private Limited reported revenue of ₹10.72 Cr (up 7% YoY) for FY 2025.

Revenue · FY 2025
₹10.72 Cr ▲ 7%
Net loss · FY 2025
₹1.31 Cr margin -12.2%
EBITDA · FY 2025
-₹1.01 Cr margin -9.4%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 7%
3 years · compounded
▲ 12%
5 years · compounded
▲ 11%
EBITDA CAGR growth
1 year
▼ 62%
3 years · compounded
▼ 63%
5 years · compounded
▼ 28%

Revenue has grown at a compounded annual rate (CAGR) of 11% over five years, including 7% growth in the latest year. EBITDA fell 62% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹1.01 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹1.31 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin-9.4%
Net Profit Margin-12.2%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of First Time Us Pharmaceuticals (India) Private Limited, buy the company report.

Board of directors of First Time Us Pharmaceuticals (India) Private Limited

First Time Us Pharmaceuticals (India) has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Vibhor Shirish MisarDirector18 Dec 201312 Years 10 MonthsCurrent
Manesh Ashok DixitDirector10 Jun 201313 Years 4 MonthsCurrent
Sachin Janardan BhusariNominee Director13 Aug 20251 Years 2 MonthsCurrent

Auditor

First Time Us Pharmaceuticals (India) Private Limited is audited by KNAV & CO. LLP for the financial year 2023.

Auditor firmFinancial yearFirm registration number
KNAV & CO. LLPFY 2023120458W

Shareholding

The shareholding of First Time Us Pharmaceuticals (India) Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of First Time Us Pharmaceuticals (India) Private Limited, buy the company report.

Deals & funding

First Time Us Pharmaceuticals (India) Private Limited has 4 deals on record (4 rights issues); the latest was in January 2019.

Total deals
4
Rights issues
4

Deals on record (4 of 4)

WhenDealAmountParties
Jan 2019Rights issue₹1.84 CrInvestors: First Time US Generics LLC
Feb 2017Rights issue₹2.57 CrInvestors: First Time US Generics LLC
Dec 2015Rights issue₹71.3 LakhInvestors: First Time US Generics LLC
Mar 2014Rights issue₹2.76 CrInvestors: First Time US Generics LLC

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

No delayed payments to MSME suppliers are on our record for First Time Us Pharmaceuticals (India) Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

First Time Us Pharmaceuticals (India) Private Limited has a workforce of 48 employees on its EPFO records as of Mar 27, 2024, across 1 active EPFO establishment.

Employee count
48
Active EPFO establishments
1
Employee growth
20%

GST

First Time Us Pharmaceuticals (India) has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
27AACCF2726R1Z7MaharashtraActive01 Jul 2017

To see the full GST registrations and return filing status of First Time Us Pharmaceuticals (India) Private Limited, buy the company report.

Recent activity

First Time Us Pharmaceuticals (India) Private Limited has 7 board changes on record since 2013: 4 appointments and 3 cessations. The latest: Sachin Janardan Bhusari was appointed as Nominee Director on 13 Aug 2025.

AGM
First Time Us Pharmaceuticals (India) Private Limited last Annual general meeting of members was held on 30 Oct 2025 as per latest MCA records.
Appointed
Sachin Janardan Bhusari was appointed as Nominee Director.
Ceased
Priyanka Shirishkumar Misar ceased to be Director.
Filing
First Time Us Pharmaceuticals (India) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Ceased
Ashok Arjun Mhaske ceased to be Additional Director.
Ceased
Vibhor Shirish Misar ceased to be Additional Director.
Appointed
Vibhor Shirish Misar was appointed as Director.
Appointed
Manesh Ashok Dixit was appointed as Director.
Appointed
Priyanka Shirishkumar Misar was appointed as Director.
Incorporation
10 Jun 2013
First Time Us Pharmaceuticals (India) Private Limited was registered on 10 Jun 2013 with Roc Mumbai & aged 13 years 4 months as per MCA records.

Frequently asked questions

First Time Us Pharmaceuticals (India) is an active foreign private limited company based in Navi Mumbai, Maharashtra, India. The company works in medical equipment retail and distribution, within the healthcare industry. It was incorporated on 10 June 2013 (13+ years old) and is registered under CIN U74999MH2013FTC244256.

First Time Us Pharmaceuticals (India) has 3 current directors:

The latest financial statements of First Time Us Pharmaceuticals (India) on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 October 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of First Time Us Pharmaceuticals (India) is 27AACCF2726R1Z7, registered in Maharashtra.

The CIN (Corporate Identification Number) of First Time Us Pharmaceuticals (India) is U74999MH2013FTC244256. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

First Time Us Pharmaceuticals (India) has 1 court case on record: 1 filed by the company.

First Time Us Pharmaceuticals (India) was incorporated on 10 June 2013, making it 13+ years old. It is registered with the Registrar of Companies, Mumbai.

First Time Us Pharmaceuticals (India) has 4 deals on record (4 rights issues); the latest was in January 2019.

Sachin Janardan Bhusari was appointed as Nominee Director on 13 Aug 2025. Priyanka Shirishkumar Misar ceased to be Director on 29 Jul 2025. Ashok Arjun Mhaske ceased to be Additional Director on 30 Sep 2015. First Time Us Pharmaceuticals (India) has 7 board changes on record in total.

First Time Us Pharmaceuticals (India) can be reached through the website firsttimeusgenerics.com. Its registered office is in Navi Mumbai, Maharashtra, India.